Cargando…
Liquid Biopsy in Glioblastoma
SIMPLE SUMMARY: Glioblastoma is the most common and malignant primary brain tumor. Despite intensive research for new treatments, the survival of patients has not significantly improved in recent decades. Currently, glioblastoma is mainly diagnosed by neuroimaging techniques followed by histopatholo...
Autores principales: | Ronvaux, Lorian, Riva, Matteo, Coosemans, An, Herzog, Marielle, Rommelaere, Guillaume, Donis, Nathalie, D’Hondt, Lionel, Douxfils, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323318/ https://www.ncbi.nlm.nih.gov/pubmed/35884454 http://dx.doi.org/10.3390/cancers14143394 |
Ejemplares similares
-
SDPS-13 CELL LINE STUDY OF NUCLEOSOME-BASED BIOMARKERS IN THE DIAGNOSIS AND DETECTION OF RELAPSES IN GLIOBLASTOMA
por: Decarpentrie, Jonathan, et al.
Publicado: (2023) -
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
por: Morimont, Laure, et al.
Publicado: (2022) -
Liquid biopsy and glioblastoma
por: Eibl, Robert H., et al.
Publicado: (2023) -
Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma
por: Wouters, Roxanne, et al.
Publicado: (2020) -
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019)